Introduction. Hospital-acquired pneumonia (HAP) is the one that presents clinically two or more 29 days after admission into the hospital. Rapid identification of the causative agent of HAP will allow 30 an earlier administration of a more appropriate antibiotic therapy and could lead to an improved 31 outcome of patients with HAP. 32
Introduction 49
Hospital-acquired pneumonia (HAP) is the one that presents clinically two or more days 50 after hospitalization and includes ventilator-associated pneumonia (VAP), which is defined as 51 pneumonia that presents after 48 hours with endotracheal intubation (1). Patients with VAP 52 present longer periods with mechanical ventilation, as well as longer stay in the ICU and in the 53 hospital (2). It is estimated that approximately 10-40% of the patients undergoing mechanical 54 ventilation for more than two days will develop VAP (2), with great differences among countries, 55 type of patient, and type of intensive care unit (ICU). The implementation of different preventive 56 strategies enabled a decrease in VAP cases, but it is still a very important problem among 57 ventilated patients (3). 58 VAP is frequently caused by Gram-negative aerobic bacteria (4-6), such as Pseudomonas 59 aeruginosa, Klebsiella pneumoniae and Acinetobacter spp; while Staphylococcus aureus is the 60 the infection in the lung; and 3) negative cultures due to previous empirical antibiotic treatment. 73
Empirical treatment is usually initiated in patients with suspected VAP before having the definitive 74 diagnosis (11), since early and adequate treatment decreases the mortality (12). However, the 75 indiscriminate administration of antibiotics exposes patients to unnecessary side effects, increases 76 health care costs and favors the appearance of antibiotic resistance. Hence, the importance of 77 knowing if there is an infection or not and the identification of the etiological agent (2). 78
The application of rapid diagnostic techniques to identify microbial pathogens seems to 79 have a huge impact in the treatment of VAP, reducing inappropriate or unnecessary antimicrobial 80 treatments and mortality in these patients (13, 14) . Molecular biology techniques have allowed a 81 faster diagnosis of VAP, especially in viral infections. They have the advantage of being faster than 82 culture, allowing the detection of the causative agents even though the patient is receiving 83 antibiotics and being able to quantify the bacterial concentration in the sample. On the other 84 hand, in general they are relatively expensive techniques and detect a limited number of 85
microorganisms. 86
The reaction based on the loop-mediated isothermal amplification (LAMP), developed in 87 2000 by Notomi et al. (15) , is a rapid, simple, cheap and constant temperature nucleic acid 88 amplification method. This method is very sensitive and specific, and there are numerous 89 publications regarding its use in a wide range of applications (16). LAMP has been used to identify 90 respiratory pathogens, with promising results (17, 18) . The purpose of this study was to develop 91 and evaluate a rapid protocol to identify the main microorganisms involved in HAP by LAMP 92 directly from respiratory samples.
Study design 95
We developed a rapid protocol to identify by LAMP six different bacteria (P. aeruginosa, 96
Acinetobacter baumannii, K. pneumoniae, Escherichia coli, S. aureus and Stenotrophomonas 97 maltophilia) and evaluated its performance compared to culture. We used three different types of 98 samples: bronchoalveolar lavage (BAL), endotracheal aspirate (EA) and bronchoaspirate (BAS). 99
Two different protocols were optimized and used to deal with the different consistencies of the 100 samples processed (aspirates being more difficult to work with due to sample thickness). 101
Collection of samples 102
Positive and negative BAL, EA and BAS samples were collected from the Clinical 103
Microbiology Laboratory at the Hospital Clinic of Barcelona (Spain), after being processed for 104 routine techniques. The microbiological result was collected, including Gram stain and culture 105 result. BAL collected during two-year period (2016/17) and EA/BAS during six months (January to 106 June 2018) were stored at -80ºC until use. To standardize the protocol, negative samples were 107 mixed to obtain a homogeneous matrix. Aliquots of this homogeneous negative sample was 108 spiked with different microorganisms and used to determine the limits of detection for each 109 microorganism. 110
Routine microbiological methods 111
Respiratory samples were collected in sterile containers and transported to the laboratory 112 in less than two hours. Gram staining of the samples in the area of maximal purulence was 113 examined for leukocytes and epithelial cells. Only respiratory samples with Murray-Washington 114 classification degrees of IV (10-25 epithelial cells and >25 leukocytes per field using a low 115 magnification lens (x100)), V (≤10 epithelial cells and >25 leukocytes) or VI (≤10 epithelial cells and 7 ≤10 leukocytes) were processed for culture. Specimens not fulfilling these criteria were not 117 considered to be representative of distal airways and were not processed for culture. 118
Good-quality respiratory specimens were quantitatively plated on blood and chocolate 119 agar. Isolated bacteria were identified by matrix-assisted laser desorption/ionization time-of-flight 120 mass spectrometry (MALDI-TOF MS) (Bruker Daltonics, Bremen, Germany Corynebacterium spp, H. parainfluenzae and coagulase-negative staphylococci and were not 126 considered as clinically significant. These samples were informed as having normal or mixed flora. 127
Extraction of DNA 128
Two protocols depending on the type of sample were performed, and they are described in 129 Master Mix (Optigene) and 5.0μL of extraction product. Once the reaction mix is ready, gentle 137 vortex and centrifugation must be performed. The reaction was conducted in a Versant kPCR 138 (Siemens) at 65°C for 40 minutes for BAL samples and in a Lightcycler (Roche) at 65ºC for 30 we performed them in two different machines because they were done in different times and 141 changes in laboratory equipment occurred. 142
Determination of the limits of detection 143
Each microorganism was inoculated into negative BAL samples to a final concentration 144 ranging from 10 7 to 10 2 CFU/mL. For EA/BAS it was not possible to perform the same study for 145 sensitivity due to the consistency of the samples and the physical impossibility of obtaining 146 homogeneous matrix for all the dilutions. Instead, positive samples were used to perform serial 147 10-fold dilutions in saline buffer. Final concentration for each dilution was based on the 148 approximate initial concentration determined by culture. 149
Statistical analysis 150
Concordance between culture and LAMP results was studied. Major errors were defined as 151 result discrepancies where the microorganism identified by LAMP was completely different from 152 that identified in culture or the detection of a pathogen when the culture had none. Minor errors 153 were defined as concordant results for the major pathogen identification but LAMP identified 154 additional microorganisms. 155
Diagnostic performance was based on sensitivity, specificity, negative-and positive-156 predictive values, and accuracy defined as described elsewhere (19, 20) . Accuracy was calculated between the LAMP assay and bacterial culture is shown. All major errors happened due to a low 186 concentration of bacterial in the sample, except for two cases: S. aureus with more than 10,000 187 CFU/mL in culture and A. baumannii with 300,000 CFU/mL in culture. 188
Regarding possible amplification inhibitors, a mix of lipidic, hematic, viscous and mucous 189 samples were used and inoculated with the different microorganisms. No evidence of interference 190 was observed in any of these prepared samples. The sensitivity, specificity, negative and positive predictive values of the LAMP assay to 194 detect pathogens directly from BAS/EA samples are shown in Table 2 . When minor errors were 195 considered as false positive results, the sensitivity was 68.9% (95%CI; 57.1% to 79.2%), the 196 specificity was 100% (95%CI; 66.4% to 100%), and the PPV and NPV were of 100% and 28.1%, 197 respectively. However, when minor errors were considered as true positive the statistical 198 indicators were: 94.6% (95%CI; 86.7% to 98.5%) sensitivity, 100% (95%CI; 66.4% to 100%) 199 specificity, 100% PPV and 69.2% (95%CI; 46.5% to 85.4%) NPV (Table 2) . 200
The time to positivity of the LAMP test was strongly correlated with the number of 201 bacterial CFU/ml in culture in EA/BAS samples (r= -0.71, P<0.01) but not in BAL samples (Figure 2) . 202
These results suggest that, at least in EA/BAS samples, the time to positivity of LAMP could be 203 used as a semi-quantitative measure.
Discussion 205
Although new preventive measures have led to a reduction of HAP incidence, it remains 206 associated with important morbi-mortality (21). Therefore, it is necessary to introduce new 207 methods to improve an early diagnosis. Here, we have evaluated the use of LAMP as a rapid 208 diagnostic tool to identify the main pathogens involved in HAP with promising results. 209
We found an overall accuracy between LAMP and culture of 88% for BAL samples and 95% Cost is also important. We have calculated that the LAMP assay (counting both reagents for 225 nucleic acid extraction and LAMP together with plastic material) to detect the six pathogens 226 causing HAP in this study will cost 12€. of the microorganism causing the infection. In addition, a semi-quantitative approach can be used 229 extrapolating the time to result with the CFU/ml in BAS and EA. In BAL the data that we had was 230 not sufficient to get a significant result (data not shown). If the quantification is under 10²-10³ 231 CFU/ml the LAMP will probably not provide a positive result, but in general culture result will be 232 considered as colonization in these cases. Therefore, every positive LAMP result should be taken 233 into consideration, always taking into account the Gram stain, quality of samples and clinical 234 situation of the patient. Culture should not be avoided in any case and LAMP could be 235 implemented as a complement to accelerate the diagnosis of HAP. 236 Furthermore, it also seems promising for the detection of resistance genes (27, 28) . 237
Pathogen identification and potential antibiotic resistance is possible with LAMP, both more 238 rapidly identified (1 hour) than with a time consuming (16 to 24 hours) classical phenotypic 239 method. And, it could be even faster when applied directly to samples (29). Diseases (REIPI RD16/0016/0010) and was co-financed by European Development Regional Fund 252 "A way to achieve Europe". This work was also supported by award 2017 SGR 0809 from the 253 
